The International Waldenstrom’s Macroglobulinemia Foundation (IWMF)
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a patient-founded and patient-led non-profit organization, comprised of 99% volunteers and represents 32,000 Waldenstrom’s patients worldwide! They want you to know with the IWMF, you are never alone and anyone can become a member. As the IWMF strives to support the lives of those living with this rare cancer, the organization offers critical services to achieve that end.
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Resources & Support
Patient Worthy Posts on Waldenstrom Macroglobulinemia
IWMF Webinar Presents Vital Info on Clinical Trials
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) recently hosted a webinar presentation on February 9, 2021. This webinar, titled “Why Clinical Trials Matter and How to
New Drug Combination Shows Promise in WM
According to a story from newswise.com, a team of researchers from the University of New Hampshire may have discovered the next new treatment for a
IMBRUVICA Prescribing Information for WM Includes iNNOVATE Data
In late December 2020, biopharmaceutical company AbbVie announced via press release that the prescribing information for IMBRUVICA (ibrutinib) is now updated to include long-term
BET Inhibitors Could Treat WM, Study Says
Waldenstrom macroglobulinemia (WM) is incredibly difficult to treat. In addition to having no cures, the condition only has one approved treatment option. However, researchers now
Waldenström’s Macroglobulinemia Precursor States: Could They be Key to a Cure?
On October 14th, 2020, the International Waldenström’s Macroglobulinemia Foundation (IWMF) hosted a webinar featuring Dr. Irene Ghobrial of the Dana Farber Cancer Institute. The focus
September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness
September 15th, 2020 is recognized as World Lymphoma Awareness Day. This day is dedicated to spreading awareness about lymphoma and falls in the context of
